Interpace Biosciences IDXG
OTC IDXG
$6.05 -0.20 (-3.20%)
At close: Nov 13, 2026 · 4:00 PM EST

Interpace Biosciences (IDXG) Return on Equity [ROE] (2009 - 2026)

Updated

Interpace Biosciences (IDXG) posted Return on Equity [ROE] of 105.55% for Q2 2026, up 1.47 percentage points from the prior quarter.

Analysis

Interpace Biosciences (IDXG) Return on Equity [ROE] (2009 - 2026) Analysis & Trends

For FY2025, Interpace Biosciences' Return on Equity [ROE] came in at 243.97%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 HCA Healthcare 105.29 Bn 103.13 Bn 17.03 Bn -
2 Natera 46.06 Bn 41.68 Bn 513.47 Mn -8.92%
3 Labcorp Holdings 30.09 Bn 28.19 Bn 1.11 Bn 11.52%
4 Quest Diagnostics 28.58 Bn 26.66 Bn 1.04 Bn 14.97%
5 Guardant Health 20.44 Bn 16.05 Bn 236.15 Mn -
6 BrightSpring Health Services 14.16 Bn 11.04 Bn 518.55 Mn 19.43%
7 Encompass Health 13.83 Bn 14.29 Bn 1.54 Bn 24.97%
8 Tempus AI 12.69 Bn 9.84 Bn 266.70 Mn -40.36%
9 Davita 11.06 Bn 9.92 Bn 1.13 Bn -
10 Interpace Biosciences 167.59 Mn 158.32 Mn 5.65 Mn 104.39%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 104.39%
Mar 31, 2026 102.90%
Dec 31, 2025 220.32%
Dec 31, 2019 -3,447.97%
Sep 30, 2019 -212.91%
Jun 30, 2019 -102.30%
Mar 31, 2019 -75.91%
Dec 31, 2018 -74.19%
Sep 30, 2018 -65.46%
Jun 30, 2018 -60.91%
Mar 31, 2018 -78.18%
Dec 31, 2017 -57.66%
Sep 30, 2017 -4.75%
Jun 30, 2017 -37.29%
Jun 30, 2016 -223.55%
Mar 31, 2016 -164.87%
Dec 31, 2015 -168.69%
Sep 30, 2015 -395.16%
Jun 30, 2015 -192.52%
Mar 31, 2015 -105.92%
API Access

Interpace Biosciences Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IDXG&period=max&api_key=YOUR_API_KEY